Zymeworks Inc.

NASDAQ: ZYME · Real-Time Price · USD
14.20
-0.10 (-0.70%)
At close: Aug 15, 2025, 2:57 PM

Zymeworks Statistics

Share Statistics

Zymeworks has 69.68M shares outstanding. The number of shares has increased by -1.92% in one year.

69.68M
-1.92%
0.15%
93.64%
73.07M
340
0.07%

Short Selling Information

The latest short interest is 6.87M, so 9.18% of the outstanding shares have been sold short.

6.87M
9.18%
11.67%
18.15

Valuation Ratios

The PE ratio is -9.05 and the forward PE ratio is -11.13. Zymeworks's PEG ratio is 1.56.

-9.05
-11.13
14.55
5.5
0
-9.82
1.56
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Zymeworks.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 3.4, with a Debt / Equity ratio of 0.05.

3.4
3.4
0.05
-175.28
-163.36
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$255.2K
$-410.35K
299
0.16
n/a

Taxes

6.08M
-5.22%

Stock Price Statistics

The stock price has increased by 20.17% in the last 52 weeks. The beta is 1.26, so Zymeworks's price volatility has been higher than the market average.

1.26
20.17%
12.87
13.21
34.26
455,790

Income Statement

In the last 12 months, Zymeworks had revenue of 76.3M and earned -122.69M in profits. Earnings per share was -1.62.

76.3M
65.11M
-119.82M
-122.69M
-105.42M
-119.82M
-1.62
Full Income Statement

Balance Sheet

The company has 66.1B in cash and 18.48B in debt, giving a net cash position of 47.63B.

66.1B
18.48B
47.63B
-830.34B
425.52M
241.36M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -110.04M and capital expenditures -3.07M, giving a free cash flow of -113.11M.

-110.04M
-3.07M
-113.11M
-1.49
Full Cash Flow Statement

Margins

Gross margin is 85.33%, with operating and profit margins of -157.03% and -160.8%.

85.33%
-157.03%
-152.82%
-160.8%
-138.16%
-157.03%
-148.24%

Dividends & Yields

ZYME does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for ZYME is $20, which is 60.6% higher than the current price. The consensus rating is "Buy".

$20
60.6%
Buy
7
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

2.72
4